FDA Unveils Rule On Generic-Brand Patent Battles
Prompted by an important U.S. Supreme Court ruling, the U.S. Food and Drug Administration on Thursday floated a lengthy regulation aimed at clarifying its policies on how brand-name drugmakers can change...To view the full article, register now.
Already a subscriber? Click here to view full article